NATR - NATURES SUNSHINE PRODUCTS INC
24.76
-0.320 -1.292%
Share volume: 167,835
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$25.08
-0.32
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-07-2024 | 08-08-2024 | 11-07-2024 | 03-11-2025 | 05-06-2025 | 07-31-2025 | 11-06-2025 | |
| Total revenue | 110.993 M | 110.551 M | 114.615 M | 118.205 M | 113.248 M | 114.750 M | 128.339 M | |
| Cost of revenue | 32.015 M | 31.664 M | 32.856 M | 33.141 M | 31.651 M | 32.451 M | 34.290 M | |
| Gross profit | 78.978 M | 78.887 M | 81.759 M | 85.064 M | 81.597 M | 82.299 M | 94.049 M | |
| -0.12% | 3.64% | 4.04% | -4.08% | 0.86% | 14.28% | |||
| Operating expenses | 40.784 M | 38.557 M | 40.954 M | 43.709 M | 40.581 M | 43.665 M | 45.726 M | |
| Selling general and admin | 40.784 M | 38.557 M | 40.954 M | 43.709 M | 40.581 M | 43.665 M | 45.726 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 74.354 M | 73.250 M | 76.475 M | 80.514 M | 75.425 M | 78.025 M | 85.074 M | |
| -1.48% | 4.40% | 5.28% | -6.32% | 3.45% | 9.03% | |||
| Operating income | 4.624 M | 5.637 M | 5.284 M | 4.550 M | 6.172 M | 4.274 M | 8.975 M | |
| Ebit | 4.655 M | 4.423 M | 7.899 M | 1.418 M | 6.925 M | 7.300 M | 9.647 M | |
| Pretax income | 4.655 M | 4.423 M | 7.899 M | 1.449 M | 7.109 M | 7.544 M | 9.672 M | |
| -4.98% | 78.59% | -81.66% | 390.61% | 6.12% | 28.21% | |||
| Income tax | 2.165 M | 2.935 M | 3.253 M | 2.181 M | 2.225 M | 2.025 M | 4.137 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 2.490 M | 1.488 M | 4.646 M | -732.000 K | 4.884 M | 5.519 M | 5.535 M | |
| -40.24% | 212.23% | -115.76% | 767.21% | 13.00% | 0.29% |